Conmed (CNMD) Cash from Investing Activities (2010 - 2026)

Conmed (CNMD) has 17 years of Cash from Investing Activities data on file, last reported at $11.6 million in Q2 2026.

• Quarterly Cash from Investing Activities rose 301.89% year-over-year to $11.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.4 million (up 120.95% YoY) and the FY2025 annual result came in at -$21.0 million, down 60.17% from the prior year.
• Cash from Investing Activities improved to $11.6 million in Q2 2026, from $4.1 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $11.6 million in Q2 2026 to a low of -$148.3 million in Q2 2022.
• A 5-year average of -$16.0 million and a median of -$4.6 million in 2023 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities plunged 4852.1% — and 2026, when it jumped 301.89%.
• Tracing CNMD's Cash from Investing Activities over 5 years: stood at -$6.3 million in 2022, then gained by 23.16% to -$4.9 million in 2023, then increased by 16.79% to -$4.0 million in 2024, then slumped by 76.01% to -$7.1 million in 2025, then surged by 262.65% to $11.6 million in 2026.
• The last three Cash from Investing Activities figures came in at $11.6 million (Q2 2026), $4.1 million (Q1 2026), and -$7.1 million (Q4 2025), per Business Quant data.